Company intelligence / Profile preview
VaxInnate Corporation
Cranbury, New Jersey, United Statesvaxinnate.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
As of 2015, VaxInnate had completed Phase 1 trials for its quadrivalent seasonal influenza vaccine candidate VAX2012Q and was advancing to Phase 1b/2 trials in healthy adults and elderly populations[5][6]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Recombinant vaccines
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
BARDA (Biomedical Advanced Research and Development Authority)
Beyond the preview
Go deeper on VaxInnate Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VaxInnate Corporation.